Several CTD features were also observed in iPAH patients (ANA in 8 cases, antiphospholipid-antibodies/LAC and alopecia in 2, fever and anti-Ro positivity in 1 respectively) but did not affect patients’ reclassification. This evidence concerns the gene CALR and idiopathic pulmonary arterial hypertension.